VC  Redmile Group

http://redmilegroup.com/





     Office Locations:

One Letterman Drive Building D, Suite D3-300
The Presidio of San Francisco
San Francisco, CA 94129
Phone: 415-989-3639

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Redmile Group invests in both privately held and publicly traded Life Sciences and Medical Device securities. Redmile has disclosed 69 total holdings in their latest SEC filings. Most recent portfolio value is calculated to be $ 3,566,983,000 USD. Redmile Group, LLC's top holdings are Fate Therapeutics, Inc. (US:FATE), Amicus Therapeutics, Inc. (US:FOLD), Deciphera Pharmaceuticals, Inc. (US:DCPH), Biogen Inc. (US:BIIB), and IGM Biosciences, Inc. (US:IGMS). Redmile Group, LLC's new positions include Beam Therapeutics Inc. (US:BEAM), 1Life Healthcare, Inc. (US:ONEM), Zymeworks Inc (US:ZYME), PPD, Inc. (US:PPD), and Twist Bioscience Corp (US:TWST).


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Amrit Nagpal Managing Director
    Gerard van Hamel Platerink Managing Director
    Rob Faulkner Managing Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      11/06/2021


      GRO Biosciences


      MA


      $25,000,000


      Series A


      04/29/2021


      Ceribell


      CA


      $53,000,000


      Series C


      04/28/2021


      Boundless Bio


      CA


      $105,000,000


      Series B


      04/20/2021


      Adagio Therapeutics


      MA


      $336,000,000


      Series C


      03/31/2021


      Entrada Therapeutics


      MA


      $116,000,000


      Series B


      03/16/2021


      ElevateBio


      MA


      $525,000,000


      Series C


      03/04/2021


      Amunix


      CA


      $117,000,000


      Series B


      01/19/2021


      Verve Therapeutics


      MA


      $94,000,000


      Series B


      01/13/2021


      Impulse Dynamics


      NJ


      $60,000,000


      Series D


      12/16/2020


      Neuron23


      CA


      $113,500,000


      Series A and B


      12/16/2020


      Neurogene


      NY


      $115,000,000


      Series B


     

    Portfolio companies include:


      Adagio Therapeutics
        web link


      Afferent Pharmaceuticals
        web link


      Akero Therapeutics
        web link


      Amunix
        web link


      Annexon Biosciences
        web link


      Aprea Therapeutics
        web link


      Atreca
        web link


      Attenua
        web link


      Augmedix
        web link


      Avalanche Biotechnologies
        web link


      Beam Therapeutics
        web link


      Blueprint Medicines
        web link


      Boundless Bio
        web link


      Castlight Health
        web link


      Ceribell
        web link


      CorVent Medical
        web link


      Deciphera Pharmaceuticals
        web link


      ElevateBio
        web link


      Entrada Therapeutics
        web link


      First Aid Shot Therapy (F.A.S.T.)
        web link


      Foundation Medicine
        web link


      Genalyte
        web link


      Gritstone Oncology
        web link


      GRO Biosciences
        web link


      IGM Biosciences
        web link


      Impulse Dynamics
        web link


      Invitae


      Jounce Therapeutics
        web link


      Kymera Therapeutics
        web link


      LifeSprout
        web link


      Neurogene
        web link


      Neuron23
        web link


      Nurix Therapeutics
        web link


      Nuvation Bio
        web link


      OncoResponse
        web link


      One Medical Group
        web link


      Ovid Therapeutics
        web link


      Pliant Therapeutics
        web link


      Repare Therapeutics
        web link


      Replimune
        web link


      Scanadu
        web link


      Scholar Rock
        web link


      Science 37
        web link


      Scioderm
        web link


      Shattuck Labs
        web link


      Stoke Therapeutics
        web link


      Syros Pharmaceuticals
        web link


      TCR2 Therapeutics
        web link


      TriVascular
        web link


      True North Therapeutics
        web link


      Verve Therapeutics
        web link


      Virta Health
        web link


      WaVe Life Sciences
        web link


      Yumanity Therapeutics
        web link


      Zentalis Pharmaceuticals
        web link


     

    Recent News: